0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

Humana Inc

Healthcare US HUM

311.41USD
-4.57(1.45%)

Last update at 2024-04-25T20:10:00Z

Day Range

308.19315.70
LowHigh

52 Week Range

422.53539.16
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 3568.00M 3354.00M 4600.00M 3456.00M 2063.00M
Minority interest 4.00M -1.00000M - - -
Net income 2806.00M 2933.00M 3367.00M 2707.00M 1683.00M
Selling general administrative - 10121.00M 10052.00M 7381.00M 7525.00M
Selling and marketing expenses - - - - -
Gross profit 80199.00M 72943.00M 67103.00M 57507.00M 49387.00M
Reconciled depreciation 845.00M 713.00M 616.00M 575.00M 534.00M
Ebit 3969.00M 3418.00M 4674.00M 3470.00M 2292.00M
Ebitda 4814.00M 4131.00M 5290.00M 4045.00M 2826.00M
Depreciation and amortization 845.00M 713.00M 616.00M 575.00M 534.00M
Non operating income net other 165.00M 597.00M -29.00000M 520.00M -819.00000M
Operating income 3969.00M 3418.00M 4674.00M 3470.00M 2292.00M
Other operating expenses 89302.00M 79710.00M 72555.00M 61432.00M 54849.00M
Interest expense 401.00M 326.00M 283.00M 242.00M 218.00M
Tax provision 762.00M 485.00M 1307.00M 763.00M 391.00M
Interest income 401.00M 326.00M 283.00M 242.00M 218.00M
Net interest income -401.00000M -326.00000M -283.00000M -242.00000M -218.00000M
Extraordinary items - - - 0.00000M -39.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 762.00M 485.00M 1307.00M 763.00M 391.00M
Total revenue 92870.00M 83064.00M 77155.00M 64888.00M 56912.00M
Total operating expenses 89070.00M -79646.00000M -72481.00000M -61418.00000M 53812.00M
Cost of revenue 12671.00M 10121.00M 10052.00M 7381.00M 7525.00M
Total other income expense net -401.00000M -64.00000M -74.00000M -14.00000M -229.00000M
Discontinued operations - - - - -
Net income from continuing ops 2802.00M 2934.00M 3293.00M 2693.00M 2454.00M
Net income applicable to common shares 2806.00M 2933.00M 3367.00M 2707.00M 1683.00M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 43055.00M 44343.00M 34969.00M 29074.00M 25413.00M
Intangible assets 1765.00M 2639.00M 329.00M 177.00M 245.00M
Earning assets - - - - -
Other current assets 5567.00M 6493.00M 5276.00M 3806.00M 3564.00M
Total liab 27685.00M 28240.00M 21241.00M 17037.00M 15252.00M
Total stockholder equity 15311.00M 16080.00M 13728.00M 12037.00M 10161.00M
Deferred long term liab - - - - -
Other current liab 9526.00M -254.00000M -318.00000M -247.00000M -283.00000M
Common stock 33.00M 33.00M 33.00M 33.00M 33.00M
Capital stock 33.00M 33.00M 33.00M 33.00M 33.00M
Retained earnings 25492.00M 23086.00M 20517.00M 17483.00M 15072.00M
Other liab 1017.00M 2371.00M 1787.00M 809.00M 800.00M
Good will 9142.00M 11092.00M 4447.00M 3928.00M 3897.00M
Other assets 43055.00M -2335.00000M -5150.00000M -5332.00000M -5332.00000M
Cash 5061.00M 3394.00M 4673.00M 4054.00M 2343.00M
Cash and equivalents 5061.00M 3394.00M 4673.00M 4054.00M 2343.00M
Total current liabilities 17178.00M 15074.00M 13076.00M 10888.00M 10013.00M
Current deferred revenue 286.00M 254.00M 318.00M 247.00M 283.00M
Net debt 6363.00M 9426.00M 2307.00M 1837.00M 3897.00M
Short term debt 2390.00M 2279.00M 920.00M 924.00M 1865.00M
Short long term debt 2390.00M 2279.00M 920.00M 924.00M 1865.00M
Short long term debt total 11424.00M 12820.00M 6980.00M 5891.00M 6240.00M
Other stockholder equity -8910.00000M -7081.00000M -7213.00000M -5635.00000M -4785.00000M
Property plant equipment 3221.00M 3073.00M 2371.00M 1955.00M 1735.00M
Total current assets 26183.00M 18400.00M 18365.00M 16082.00M 13384.00M
Long term investments 15010.00M 14113.00M 2382.00M 1469.00M 1458.00M
Net tangible assets 6169.00M 4988.00M 9281.00M 8109.00M 6264.00M
Short term investments 13881.00M 13192.00M 12554.00M 10972.00M 10026.00M
Net receivables 1674.00M 1814.00M 1138.00M 1056.00M 1015.00M
Long term debt 9034.00M 10541.00M 6060.00M 4967.00M 4375.00M
Inventory - -6493.00000M -5276.00000M -3806.00000M -3564.00000M
Accounts payable 14502.00M 12795.00M 12156.00M 9964.00M 8148.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 59.00M 23.00M - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1304.00000M 42.00M 391.00M 156.00M -159.00000M
Additional paid in capital - - - - -
Common stock total equity 33.00M 33.00M 33.00M 33.00M 33.00M
Preferred stock total equity - - - - -
Retained earnings total equity 25492.00M 23086.00M 20517.00M 17483.00M 15072.00M
Treasury stock - -10163.00000M -9918.00000M -8455.00000M -7320.00000M
Accumulated amortization - - - - -
Non currrent assets other -10501.00000M -28278.00000M -21754.00000M -18324.00000M -17361.00000M
Deferred long term asset charges - - - - -
Non current assets total 16872.00M 28278.00M 21754.00M 18324.00M 17361.00M
Capital lease obligations - - - - -
Long term debt total 9034.00M 10541.00M 6060.00M 4967.00M 4375.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1006.00000M -1053.00000M -1392.00000M -542.00000M -1316.00000M
Change to liabilities 1019.00M -65.00000M 2738.00M 1613.00M -424.00000M
Total cashflows from investing activities -1006.00000M -6556.00000M -3065.00000M -1278.00000M -3087.00000M
Net borrowings -1428.00000M 3764.00M 1078.00M -369.00000M 1165.00M
Total cash from financing activities -1914.00000M 3015.00M -1955.00000M -2295.00000M -785.00000M
Change to operating activities 556.00M -211.00000M 2157.00M 1731.00M -908.00000M
Net income 2802.00M 2934.00M 3367.00M 2707.00M 1683.00M
Change in cash 1667.00M -1279.00000M 619.00M 1711.00M -1699.00000M
Begin period cash flow 3394.00M 4673.00M 4054.00M 2343.00M 4042.00M
End period cash flow 5061.00M 3394.00M 4673.00M 4054.00M 2343.00M
Total cash from operating activities 4587.00M 2262.00M 5639.00M 5284.00M 2173.00M
Issuance of capital stock - - - - -
Depreciation 845.00M 713.00M 616.00M 575.00M 534.00M
Other cashflows from investing activities 114.00M -5240.00000M -709.00000M -542.00000M -1159.00000M
Dividends paid -392.00000M -354.00000M -323.00000M -291.00000M 265.00M
Change to inventory - 280.00M - - -
Change to account receivables -54.00000M -280.00000M -85.00000M -32.00000M -164.00000M
Sale purchase of stock -2096.00000M -79.00000M -1820.00000M -1070.00000M -1090.00000M
Other cashflows from financing activities 3574.00M -337.00000M -939.00000M -623.00000M -640.00000M
Change to netincome 201.00M -828.00000M 351.00M 401.00M 1052.00M
Capital expenditures 1120.00M 1316.00M 964.00M 736.00M 612.00M
Change receivables -54.00000M -280.00000M -85.00000M -32.00000M -200.00000M
Cash flows other operating -226.00000M -426.00000M -1348.00000M 20.00M -472.00000M
Exchange rate changes - - - - -
Cash and cash equivalents changes 1667.00M -1279.00000M 619.00M 1711.00M -1699.00000M
Change in working capital 534.00M -556.00000M 2143.00M 1663.00M -1167.00000M
Stock based compensation 216.00M 180.00M 181.00M 163.00M 137.00M
Other non cash items 290.00M -1024.00000M -863.00000M 14.00M 792.00M
Free cash flow 3467.00M 946.00M 4675.00M 4548.00M 1561.00M

Fundamentals

  • Previous Close 315.98
  • Market Cap57071.80M
  • Volume1837205
  • P/E Ratio19.16
  • Dividend Yield0.76%
  • EBITDA5201.00M
  • Revenue TTM102351.00M
  • Revenue Per Share TTM821.03
  • Gross Profit TTM 17180.00M
  • Diluted EPS TTM24.20

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
HUM
Humana Inc		 -4.57 1.45% 311.41 19.16 14.60 0.56 3.37 0.53
UNH
UnitedHealth Group Incorporated		 6.56 1.35% 493.86 22.57 18.38 1.33 5.65 1.38 13.97
ELV
Elevance Health Inc		 5.95 1.11% 539.68 18.00 12.66 0.65 2.87 0.74
CVS
CVS Health Corp		 -0.44 0.65% 67.33 12.06 9.08 0.29 1.34 0.47 8.96
CI
Cigna Corp		 2.23 0.63% 354.51 16.80 10.45 0.46 1.90 0.58

Reports Covered

Stock Research & News

View All

Profile

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Inc

Humana Building, Louisville, KY, United States, 40202

Key Executives

Name Title Year Born
Mr. Bruce Dale Broussard Pres, CEO & Director 1962
Ms. Susan Marie Diamond Chief Financial Officer 1974
Mr. Timothy S. Huval Chief Admin. Officer 1966
Mr. Timothy Alan Wheatley Segment Pres of Retail 1968
Dr. William Kevin Fleming Pharm.D., PharmD, RPh Chief Corp. Affairs Officer & Segment Pres of Pharmacy Solutions 1968
Mr. John-Paul William Felter Sr. VP, Chief Accounting Officer, Principal Accounting Officer & Controller 1983
Mr. Sam M. Deshpande Chief Information Officer 1965
Lisa M. Stoner VP of Investor Relations NA
Mr. Joseph C. Ventura Chief Legal Officer 1977
Amy Fry Sr. VP of Corp. Communications NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).